secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2024-11-19T23:59:59+00:00
Accession:  0000920148-24-000121
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp names Julia Wang CFO effective Dec 2; Glenn Eisenberg to retire April 2025
--------------------------------------------------------------------------------

- Julia Wang, former CFO of BeiGene, appointed EVP and CFO of Labcorp effective Dec 2, 2024.
- Glenn Eisenberg to retire April 30, 2025; remains special advisor to CEO through April 2025.
- Eisenberg oversaw ~100 acquisitions totaling ~$11B and more than doubled Labcorp revenues during his decade as CFO.
- Wang receives $725K base salary, 100% target bonus, $400K sign-on bonus, and $3.2M in equity grants.
- Wang previously held CFO/senior finance roles at BeiGene, Alexion, Quest Diagnostics, J&J, and PepsiCo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014824000121/0000920148-24-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014824000121/lh-20241115.htm
  HTML page:      https://secwatch.observer/filing/0000920148-24-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer